Review of effects of anti-VEGF treatment on refractive error

References

• GeloneckMMChuangAZClarkWLRefractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trialJAMA Ophthalmol2014132111327133325103848
   PubMed Web of Science ®Google Scholar
• QuinnGEDobsonVKivlinJPrevalence of myopia between 3 months and 5½ years in preterm infants with and without retinopathy of prematurityOphthalmology19981057129213009663236
   PubMed Web of Science ®Google Scholar
• QuinnGEDobsonVDavittBVProgression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings to 3 years of ageOphthalmology2008115610581064.e118423871
   PubMed Web of Science ®Google Scholar
• QuinnGEDobsonVDavittBVProgression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of ageJ AAPOS201317212412823622444
   PubMed Web of Science ®Google Scholar
• NissenkornIYassurYMashkowskiDSherfIBen-SiraIMyopia in premature babies with and without retinopathy of prematurityBr J Ophthalmol19836731701736687430
   PubMed Web of Science ®Google Scholar
• O’ConnorARStephensonTJohnsonALong-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurityPediatrics20021091121811773536
   PubMed Web of Science ®Google Scholar
• O’ConnorARStephensonTJJohnsonATobinMJRatibSFielderARChange of refractive state and eye size in children of birth weight less than 1701 gBr J Ophthalmol200690445646016547327
   PubMed Web of Science ®Google Scholar
• CookAWhiteSBatterburyMClarkDOcular growth and refractive error development in premature infants with or without retinopathy of prematurityInvest Ophthalmol Vis Sci200849125199520719036998
   PubMed Web of Science ®Google Scholar
• Mintz-HittnerHARhodesLMMcPhersonARAnterior segment abnormalities in cicatricial retinopathy of prematurityOphthalmology1979865803816583499
   PubMed Web of Science ®Google Scholar
• WuWCLinRIShihCPVisual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurityOphthalmology201211991907191622578258
   PubMed Web of Science ®Google Scholar
• LueCLHansenRMReisnerDSFindlOPetersenAFultonABThe course of myopia in children with mild retinopathy of prematurityVision Res1995359132913357610594
   PubMed Web of Science ®Google Scholar
• WangJRenXShenLYanniSELefflerJNBirchEEDevelopment of refractive error in individual children with regressed retinopathy of prematurityInvest Ophthalmol Vis Sci20135496018602423920368
   PubMed Web of Science ®Google Scholar
• ChenTCTsaiTHShihYFLong-term evaluation of refractive status and optical components in eyes of children born prematurelyInvest Ophthalmol Vis Sci201051126140614820688740
   PubMed Web of Science ®Google Scholar
• FledeliusHCFledeliusCEye size in threshold retinopathy of prematurity, based on a Danish preterm infant series: early axial eye growth, pre- and postnatal aspectsInvest Ophthalmol Vis Sci20125374177418422628207
   PubMed Web of Science ®Google Scholar
• YangCSWangAGShihYFHsuWMLong-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of ageActa Ophthalmol2013914e276e28223601812
   PubMed Web of Science ®Google Scholar
• AlgawiKGogginMO’KeefeMRefractive outcome following diode laser versus cryotherapy for eyes with retinopathy of prematurityBr J Ophthalmol19947886126147918287
   PubMed Web of Science ®Google Scholar
• LawsFLawsDClarkDCryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal studyBr J Ophthalmol199781112159135401
   PubMed Web of Science ®Google Scholar
• McLooneEMO’KeefeMMcLooneSFLaniganBMLong-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurityJ AAPOS200610545445917070482
   PubMed Web of Science ®Google Scholar
• QuinnGEDobsonVSiatkowskiRDoes cryotherapy affect refractive error? Results from treated versus control eyes in the Cryotherapy for Retinopathy of Prematurity trialOphthalmology2001108234334711158812
   PubMed Web of Science ®Google Scholar
• WuWCKuoHKYehPTYangCMLaiCCChenSNAn updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in TaiwanAm J Ophthalmol20131551150158.e122967867
   PubMed Web of Science ®Google Scholar
• Martínez-CastellanosMASchwartzSHernández-RojasMLLong-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-upRetina201333232933823099498
   PubMed Web of Science ®Google Scholar
• HarderBCSchlichtenbredeFCvon BaltzSJendritzaWJendritzaBJonasJBIntravitreal bevacizumab for retinopathy of prematurity: refractive error resultsAm J Ophthalmol2013155611191124.e123490192
   PubMed Web of Science ®Google Scholar
• ChenYHChenSNLienRIRefractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomesEye (Lond)20142891080108625104736
   PubMed Web of Science ®Google Scholar
• SalmanAGSaidAMStructural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retin-opathy of prematurityOphthalmic Res2015531152025471087
   PubMed Web of Science ®Google Scholar
• IsaacMMireskandariKTehraniNTreatment of type 1 retin-opathy of prematurity with bevacizumab versus laserJ AAPOS201519214014425892041
   PubMed Web of Science ®Google Scholar
• KuoHKSunITChungMYChenYHRefractive error in patients with retinopathy of prematurity after laser photocoagulation or bevacizumab monotherapyOphthalmologica2015234421121726393895
   PubMed Web of Science ®Google Scholar
• ChenSNLianIHwangYCIntravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumabRetina201535466767425462435
   PubMed Web of Science ®Google Scholar
• HwangCKHubbardGBHutchinsonAKLambertSROutcomes after intravitreal bevacizumab versus laser photocoagulation for retin-opathy of prematurity: a 5-year retrospective analysisOphthalmology201512251008101525687024
   PubMed Web of Science ®Google Scholar
• GunayMCelikGGunayBOAktasAKaratekinGOvaliFEvaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurityArq Bras Oftalmol2015785300300426466229
   PubMed Web of Science ®Google Scholar
• Mintz-HittnerHAKennedyKAChuangAZEfficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurityN Engl J Med2011364760361521323540
   PubMed Web of Science ®Google Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative GroupRevised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity random-ized trialArch Ophthalmol2003121121684169414662586
   PubMedGoogle Scholar
• HarderBCvon BaltzSSchlichtenbredeFCJonasJBEarly refractive outcome after intravitreous bevacizumab for retinopathy of prematurityArch Ophthalmol2012130680080122801850
   PubMedGoogle Scholar
• Mintz-HittnerHAKretzerFLPostnatal retinal vascularization in former preterm infants with retinopathy of prematurityOphthalmology199410135485588127576
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative GroupMulticenter trial of cryotherapy for retinopathy of prematurity: preliminary resultsArch Ophthalmol198810644714792895630
   PubMedGoogle Scholar
• MichaelAJPesinSRKatzLJTasmanWSManagement of late-onset angle-closure glaucoma associated with retinopathy of prematurityOphthalmology1991987109310981891218
   PubMed Web of Science ®Google Scholar
• RitchRChangBMLiebmannJMAngle closure in younger patientsOphthalmology2003110101880188914522758
   PubMed Web of Science ®Google Scholar
• Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for neovascular age-related macular degeneration: two-year resultsOphthalmology201211971388139822555112
   PubMed Web of Science ®Google Scholar
• BakriSJSnyderMRReidJMPulidoJSSinghRJPharma-cokinetics of intravitreal bevacizumab (Avastin)Ophthalmology2007114585585917467524
   PubMed Web of Science ®Google Scholar
• BakriSJSnyderMRReidJMPulidoJSEzzatMKSinghRJPharma-cokinetics of intravitreal ranibizumab (Lucentis)Ophthalmology2007114122179218218054637
   PubMed Web of Science ®Google Scholar
• SatoTWadaKArahoriHSerum concentrations of bevaci-zumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurityAm J Ophthalmol2012153232733321930258
   PubMed Web of Science ®Google Scholar
• MatsuyamaKOgataNMatsuokaMWadaMTakahashiKNishimuraTPlasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumabBr J Ophthalmol20109491215121820538658
   PubMed Web of Science ®Google Scholar
• TolentinoMSystemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular diseaseSurv Ophthalmol2011569511321335144
   PubMed Web of Science ®Google Scholar
• ZhouYJiangYBaiYWenJChenLVascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumabGraefes Arch Clin Exp Ophthalmol20162541313625851862
   PubMed Web of Science ®Google Scholar
• RobinsonGSJuMShihSCNonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal developmentFASEB J20011571215121711344092
   PubMed Web of Science ®Google Scholar